With a New Identity, Travere Thearpeutics Seeks to Find Its True Path
RARECast - A podcast by RARECast - Giovedì
Categorie:
Eric Dube, CEO of Travere Therapeutics, discusses the company’s new identity, its experimental therapy sparsentan, and the rare kidney diseases it is being developed to treat.
